Scinai Immunotherapeutics Ltd Sustainability Reports
Scinai Immunotherapeutics Ltd. is a biopharmaceutical company focused on developing, manufacturing, and commercializing biological products for autoimmune and infectious diseases. The company operates two main units: one for developing nanosized antibodies and another providing boutique CDMO services to biotechnology companies.
Sector: Manufacturing
Country: Israel
Exchange: Nasdaq
LEI: 549300VWSLMYAANYZ711
1 reports from 2024 to 2024
Company Profile
Scinai Immunotherapeutics Ltd. is a biopharmaceutical company focused on developing, manufacturing, and commercializing biological products for autoimmune and infectious diseases. The company operates two main units: one for developing nanosized antibodies and another providing boutique CDMO services to biotechnology companies.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years